Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort studyMadeleine Scott, Purvesh Khatri, Jonathan A. Kropski et al.|The Lancet Respiratory Medicine|2019Cited by 249
Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort studyJose D. Herazo‐Maya, Naftali Kaminski, William Cookson et al.|The Lancet Respiratory Medicine|2017Cited by 191
Transcriptional regulatory model of fibrosis progression in the human lungJohn E. McDonough, Naftali Kaminski, Milica Vukmirovic et al.|JCI Insight|2019Cited by 184
Validation of the prognostic value of <scp>MMP</scp>‐7 in idiopathic pulmonary fibrosisArgyris Tzouvelekis, Naftali Kaminski, Mridu Gulati et al.|Respirology|2016Cited by 134